HMGA2 and breast carcinoma: In addition, the inverse correlations were observed when HMGA2 was knocked down in MDA-MB-231 breast cancer cells (Supplementary Figure S4A (i,ii)); CTCF and Pol II recruitment to the CDH1 promoter were correspondingly enhanced.